TTC17 and breast cancer: By summarizing all the above screening results, TTC17 was identified as a metastasis suppressor in BC through genome-scale CRISPR screening, WES and RNA-seq of BC tissues and a mouse model of lung metastasis, and its deletion in BC enhanced metastasis potential.